Global Superdisintegrants Market Report and Forecast 2023-2031

Global Superdisintegrants Market Report and Forecast 2023-2031

Global Superdisintegrants Market Outlook:

The global superdisintegrants market value was USD 394.8 million in 2022, driven by the increasing regulatory guidelines and quality standards imposed by regulatory bodies across the globe. The market size is anticipated to grow at a CAGR of 7.3% during the forecast period of 2023-2031 to achieve a value of USD 741.2 million by 2031.

Superdisintegrants: Introduction

Superdisintegrants are pharmaceutical excipients used in the formulation of oral solid dosage forms to enhance disintegration and dissolution rates. They play a crucial role in the rapid disintegration of tablets or capsules in the gastrointestinal tract, facilitating drug release and absorption. Superdisintegrants aid in improving the bioavailability and therapeutic efficacy of orally administered drugs.

Key Trends in the Superdisintegrants Market

Some key trends involved in the superdisintegrants market are as follows:

Growing Demand for Fast-Acting Formulations: The demand for fast-acting oral dosage forms has increased due to the need for immediate drug release and onset of action. Superdisintegrants offer an effective solution by promoting rapid disintegration, which is especially beneficial for drugs with a narrow absorption window or those requiring quick therapeutic effects.
Technological Advancements: Continuous research and development efforts have led to the development of new and improved superdisintegrant materials with enhanced performance characteristics. These advancements include the use of novel polymers, co-processed excipients, and surface modified particles, which offer better disintegration properties and compatibility with different drug formulations.
Growing Popularity of Orally Disintegrating Tablets (ODTs): Orally disintegrating tablets have gained popularity due to their convenience, ease of administration, and patient compliance. Superdisintegrants are key components in ODT formulations, as they facilitate rapid disintegration and provide a pleasant mouthfeel. The increasing demand for ODTs across various therapeutic areas has driven the market for superdisintegrants.
Increasing Focus on Pediatric and Geriatric Formulations: Pediatric and geriatric patients often face difficulties in swallowing conventional tablets or capsules. Superdisintegrants offer a solution by improving the disintegration and ease of administration of oral dosage forms in these patient populations. As the demand for age-specific formulations increases, the use of superdisintegrants in pediatric and geriatric medications is expected to grow.

Superdisintegrants Market Segmentations

Market Breakup by Product Type

Synthetic Superdisintegrants
Natural Superdisintegrants
Market Breakup by Formulation Type

Tablets
Capsules
Other
Market by Therapeutic Area

Oncology
Neurology
Cardiology
Infectious Diseases
Others
Market Breakup by Applications

Pharmaceutical
Nutraceuticals
Others
Market Breakup by Region

North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Superdisintegrants Market Scenario

The market for superdisintegrants is experiencing significant growth due to the increasing demand for fast-acting oral dosage forms and the need to enhance drug absorption and bioavailability. Superdisintegrants are widely used in the pharmaceutical industry to improve the disintegration and dissolution rates of oral solid dosage forms such as tablets and capsules.

The market is driven by several factors, including the growing prevalence of chronic diseases, the rising geriatric population, and the increasing focus on patient-centric healthcare. Patients and healthcare providers are seeking formulations that offer convenience, ease of administration, and rapid onset of action. Superdisintegrants play a vital role in meeting these requirements by enabling faster drug disintegration and dissolution, leading to enhanced therapeutic outcomes.

The market for superdisintegrants is also driven by regulatory guidelines and quality standards imposed by regulatory bodies. Manufacturers are required to comply with these guidelines to ensure the safety, quality, and efficacy of pharmaceutical products containing superdisintegrants. This focus on regulatory compliance and adherence to quality standards further drives the growth and adoption of superdisintegrants in the market.

Superdisintegrants Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Ashland Global Specialty Chemicals Inc.
Roquette Frères S.A.
FMC Corporation
DFE Pharma GmbH and Co. KG
DuPont de Nemours, Inc.
BASF SE
J.M. Huber Corporation